USD 0.06
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | - USD | 0.0% |
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 5455.00 USD | 0.0% |
2020 | 5455.00 USD | -89.33% |
2019 | 51.11 Thousand USD | -1.29% |
2018 | 51.77 Thousand USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 2.22 Million USD | 2.3% |
2015 | 2.17 Million USD | -14.15% |
2014 | 2.53 Million USD | -20.47% |
2013 | 3.18 Million USD | -6.28% |
2012 | 3.39 Million USD | 12.47% |
2011 | 3.01 Million USD | 129.41% |
2010 | 1.31 Million USD | 56.75% |
2009 | 839.54 Thousand USD | -10.02% |
2008 | 933.05 Thousand USD | -46.3% |
2007 | 1.73 Million USD | 125.91% |
2006 | 769.07 Thousand USD | 161.31% |
2005 | 294.32 Thousand USD | -31.64% |
2004 | 430.51 Thousand USD | 18.56% |
2003 | 363.11 Thousand USD | 163.39% |
2002 | 137.86 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q4 | - USD | 0.0% |
2024 FY | - USD | 0.0% |
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 FY | - USD | -100.0% |
2021 Q3 | 5455.00 USD | 0.0% |
2021 FY | 5455.00 USD | 0.0% |
2021 Q2 | 5455.00 USD | 0.0% |
2021 Q1 | 5455.00 USD | 0.0% |
2020 Q2 | 86.83 Thousand USD | 0.0% |
2020 Q4 | 5455.00 USD | -93.72% |
2020 FY | 5455.00 USD | -89.33% |
2020 Q3 | 86.83 Thousand USD | 0.0% |
2020 Q1 | 86.83 Thousand USD | 69.89% |
2019 FY | 51.11 Thousand USD | -1.29% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | 51.11 Thousand USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | 51.77 Thousand USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q3 | 2.24 Million USD | 0.0% |
2017 Q1 | 2.23 Million USD | 0.56% |
2017 Q2 | 2.24 Million USD | 0.56% |
2017 FY | - USD | -100.0% |
2017 Q4 | - USD | -100.0% |
2016 Q3 | 2.21 Million USD | 0.57% |
2016 Q1 | 2.18 Million USD | 0.57% |
2016 Q2 | 2.19 Million USD | 0.58% |
2016 Q4 | 2.22 Million USD | 0.56% |
2016 FY | 2.22 Million USD | 2.3% |
2015 Q3 | 2.18 Million USD | -1.09% |
2015 FY | 2.17 Million USD | -14.15% |
2015 Q4 | 2.17 Million USD | -0.41% |
2015 Q1 | 2.29 Million USD | -9.12% |
2015 Q2 | 2.2 Million USD | -4.1% |
2014 Q1 | 3.16 Million USD | -0.55% |
2014 Q2 | 2.97 Million USD | -6.02% |
2014 Q3 | 2.82 Million USD | -5.11% |
2014 Q4 | 2.53 Million USD | -10.33% |
2014 FY | 2.53 Million USD | -20.47% |
2013 Q3 | 3.82 Million USD | 0.44% |
2013 Q2 | 3.81 Million USD | 0.4% |
2013 Q1 | 3.79 Million USD | 11.85% |
2013 FY | 3.18 Million USD | -6.28% |
2013 Q4 | 3.18 Million USD | -16.92% |
2012 FY | 3.39 Million USD | 12.47% |
2012 Q2 | 4.06 Million USD | -2.25% |
2012 Q3 | 3.45 Million USD | -15.05% |
2012 Q4 | 3.39 Million USD | -1.64% |
2012 Q1 | 4.15 Million USD | 37.71% |
2011 Q2 | 2.56 Million USD | 2.31% |
2011 FY | 3.01 Million USD | 129.41% |
2011 Q4 | 3.01 Million USD | 13.93% |
2011 Q3 | 2.64 Million USD | 3.23% |
2011 Q1 | 2.5 Million USD | 90.66% |
2010 FY | 1.31 Million USD | 56.75% |
2010 Q4 | 1.31 Million USD | -13.94% |
2010 Q1 | 1.63 Million USD | 95.0% |
2010 Q2 | 1.11 Million USD | -31.71% |
2010 Q3 | 1.52 Million USD | 36.76% |
2009 Q3 | 1.1 Million USD | -40.15% |
2009 FY | 839.54 Thousand USD | -10.02% |
2009 Q4 | 839.54 Thousand USD | -24.09% |
2009 Q2 | 1.84 Million USD | 69.6% |
2009 Q1 | 1.08 Million USD | 16.77% |
2008 Q3 | 977.5 Thousand USD | 134.67% |
2008 Q4 | 933.05 Thousand USD | -4.55% |
2008 Q2 | 416.53 Thousand USD | -65.54% |
2008 Q1 | 1.2 Million USD | -30.43% |
2008 FY | 933.05 Thousand USD | -46.3% |
2007 FY | 1.73 Million USD | 125.91% |
2007 Q4 | 1.73 Million USD | -10.51% |
2007 Q2 | 1.72 Million USD | 99.92% |
2007 Q3 | 1.94 Million USD | 12.55% |
2007 Q1 | 862.8 Thousand USD | 12.19% |
2006 Q3 | 701.47 Thousand USD | 527.96% |
2006 Q4 | 769.07 Thousand USD | 9.64% |
2006 Q2 | 111.7 Thousand USD | -68.69% |
2006 Q1 | 356.75 Thousand USD | 21.21% |
2006 FY | 769.07 Thousand USD | 161.31% |
2005 Q3 | 423.41 Thousand USD | -21.8% |
2005 Q2 | 541.43 Thousand USD | 60.75% |
2005 FY | 294.32 Thousand USD | -31.64% |
2005 Q1 | 336.82 Thousand USD | -21.76% |
2005 Q4 | 294.32 Thousand USD | -30.49% |
2004 Q3 | 786.65 Thousand USD | 124.99% |
2004 Q1 | 327.21 Thousand USD | -9.89% |
2004 FY | 430.51 Thousand USD | 18.56% |
2004 Q4 | 430.51 Thousand USD | -45.27% |
2004 Q2 | 349.63 Thousand USD | 6.85% |
2003 Q1 | 359.55 Thousand USD | -3.01% |
2003 Q2 | 306.44 Thousand USD | -14.77% |
2003 FY | 363.11 Thousand USD | 163.39% |
2003 Q4 | 363.11 Thousand USD | -3.07% |
2003 Q3 | 374.61 Thousand USD | 22.25% |
2002 Q3 | 239.18 Thousand USD | -39.17% |
2002 Q2 | 393.18 Thousand USD | 222.98% |
2002 Q1 | 121.73 Thousand USD | -9.15% |
2002 FY | 137.86 Thousand USD | 0.0% |
2002 Q4 | 370.72 Thousand USD | 54.99% |
2001 Q3 | 213.8 Thousand USD | 18.56% |
2001 Q2 | 180.32 Thousand USD | 20.81% |
2001 Q4 | 134 Thousand USD | -37.32% |
2001 Q1 | 149.26 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | 100.0% |
Ansell Limited | 855.59 Million USD | 100.0% |
Ansell Limited | 857.2 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 22.41 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 20.93 Thousand USD | 100.0% |
Psykey, Inc. | 1.01 Million USD | 100.0% |
ConvaTec Group Plc | 1.31 Billion USD | 100.0% |
ConvaTec Group Plc | 1.31 Billion USD | 100.0% |
Encision Inc. | 1.33 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 100.0% |
Innovative MedTech Inc. | 1.87 Million USD | 100.0% |
LifePoint, Inc. | 446.74 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Reflect Scientific, Inc. | 242.64 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 871.79 Million USD | 100.0% |
Sector 10, Inc. | 164 Thousand USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 100.0% |
SheerVision, Inc. | 75 Thousand USD | 100.0% |
United Health Products, Inc. | 755.98 Thousand USD | 100.0% |
Vasamed, Inc. | 23.45 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 100.0% |
Yubo International Biotech Limited | 790.49 Thousand USD | 100.0% |